Drug Topics

JANUARY 16, 2024

By getting involved in patient care, pharmacists can help alleviate the burdens associated with the self-management of type 2 diabetes (T2D).

Patient Care 223

Patient Care 223

Pharmacy Times

JANUARY 16, 2024

Pharmacists are well suited to identify patients with dysphagia and educate patients and caregivers on when and how to safely crush and administer medication.

158

158

Drug Topics

JANUARY 16, 2024

Within a 12-month time frame, adjusted vaccine effectiveness against diagnosed long and probable long COVID was 41.7% and 35.4%, respectively.

Vaccines 193

Vaccines 193

Pharmacy Times

JANUARY 16, 2024

Pharmacists play a significant role in early identification, continuous monitoring, and interventions to help minimize the risk of falls in older adults.

156

156

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 16, 2024

Real-time continuous glucose monitoring (CGM) demonstrated benefits associated with time in range, hypoglycemia, and hyperglycemia in patients with type 1 diabetes (T1D).

186

186

Pharmacy Times

JANUARY 16, 2024

Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.

FDA 145

FDA 145

STAT

JANUARY 16, 2024

Last fall, the World Health Organization and some national drug regulators urged influenza vaccine manufacturers to drop the component known as B/Yamagata from flu vaccines as quickly as possible, citing the fact that this lineage of flu B viruses appears to have been snuffed out during the Covid-19 pandemic. It might seem like that request would be as simple as deciding to leave blueberries out of a mixed-fruit smoothie.

Vaccines 143

Vaccines 143

Pharmacy Times

JANUARY 16, 2024

An American Heart Association scientific statement cautions individuals with known or suspected cardiovascular disease or risk factors against shoveling snow.

139

139

STAT

JANUARY 16, 2024

The Food and Drug Administration on Tuesday approved a CRISPR-based medicine to treat beta thalassemia, an inherited blood disorder. It’s the same potentially curative therapy cleared by the FDA in December to treat sickle cell disease. The expanded approval of the therapy, called Casgevy, was widely expected but came two months ahead of the FDA’s decision deadline, known as a PDUFA date.

FDA 140

FDA 140

Pharmacy Times

JANUARY 16, 2024

Significant study results could inform clinical practice strategies.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 16, 2024

In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief. “One classmate kept asking me, are you sure?

FDA 138

FDA Medical Schools 138

Fierce Healthcare

JANUARY 16, 2024

Demand remains high for GLP-1 drugs, and the experts at Morgan Health are aiming to support employers in managing that interest with a new report. | Demand remains high for GLP-1 drugs, and the experts at Morgan Health are aiming to support employers in managing that interest with a new report.

131

131

STAT

JANUARY 16, 2024

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington. Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like th

Insurance 134

Insurance Hospitals 134

Fierce Healthcare

JANUARY 16, 2024

Innovaccer, maker of digital tools for providers, has acquired Cured, a digital marketing and customer relationship management [CRM] platform. | The strategic purchase adds more than 20 health systems and first-time digital health clients to Innovaccer’s current portfolio of customers.

128

128

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JANUARY 16, 2024

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  Hospitals want you to look here, not over there Hospital leaders took pains to draw investors’ attention to their sizable cash and investment reserves at JPM.

Hospitals 128

Hospitals Patient Care Insurance 128

Pharmacy Times

JANUARY 16, 2024

Although robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.

Compounding Pharmacies 126

Compounding Pharmacies Compounding 126

STAT

JANUARY 16, 2024

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart. The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities.

124

124

Fierce Healthcare

JANUARY 16, 2024

Rad AI, a startup that developed an AI platform for radiology, is teaming up with Google to use its cloud and large language models to streamline workflows and reduce radiologists' administrative b | Rad AI is teaming up with Google to use its cloud and large language models to power up its AI-based radiology platform. The company's technology, made by radiologists for radiologists, aims to streamline workflows and reduce repetitive tasks.

123

123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 16, 2024

Presentations detail clinical trial results and focus on drugs in the pipeline.

123

123

STAT

JANUARY 16, 2024

More than half of those responsible for registering clinical trials and reporting results fail to do so over confusion about key requirements, according to a new survey that highlighted ongoing difficulties in achieving transparency surrounding study data. Specifically, 52% said their major challenges involved sorting out the types of clinical trials that must be registered, when a trial should be registered, and when and for which trials information from summary results must be submitted to a U

123

123

Fierce Pharma

JANUARY 16, 2024

Vertex Pharmaceuticals and CRISPR Therapeutics have scored an FD | Vertex Pharmaceuticals and CRISPR Therapeutics have scored an FDA approval for their gene-editing therapy Casgevy (exa-cel) to treat transfusion-dependent beta thalassemia (TDT). The approval came more than two months ahead of the FDA's March 30 decision date.

FDA 122

FDA 122

STAT

JANUARY 16, 2024

If her social media accounts are any indication, model, cookbook author, television personality, and entrepreneur Chrissy Teigen is a wonderful mother. Many parents regard her as a role model. That’s why I found it disappointing to learn that Teigen is a spokesperson for the Cord Blood Registry, which advocates for the collection of umbilical cord blood at birth for future use.

117

117

Fierce Pharma

JANUARY 16, 2024

As British pharma giant AstraZeneca looks abroad to build new factories, GSK is sticking close to home, where it plans to plug hundreds of millions of pounds into the United Kingdom over the next t | As other British drugmakers like AstraZeneca look abroad to build new factories, GSK is sticking close to home, where it plans to plug hundreds of millions of pounds into the United Kingdom over the next two years.

116

116

Drug Store News

JANUARY 16, 2024

HRG reviewed 13 products in the health category, 38 items in the wellness sector and 27 items in the beauty aisle to see which ones stood out as Products to Watch.

116

116

Fierce Pharma

JANUARY 16, 2024

The FDA has approved Takeda's HyQvia as a maintenance therapy for CIDP. It is the second indication for HyQvia, which was first endorsed in 2014.

Immunization 116

Immunization FDA 116

pharmaphorum

JANUARY 16, 2024

DISCO Pharma has emerged from stealth with €20m in seed financing that will be used to advance its surfaceome cancer target-hunting platform

115

115

STAT

JANUARY 16, 2024

I am getting bent out of shape over surgeons telling patients they cannot get a knee replacement because they are above a certain BMI cutoff. Here’s a familiar scenario: A patient with a high body weight and BMI limps down the hall to my exam room. “How have you been?” I ask. He sighs. “I still can’t get a new knee.

113

113

pharmaphorum

JANUARY 16, 2024

In addition to bringing treatment and hope to patients without alternatives, early access programmes provide further information on a product’s safety and efficacy data in real-world conditions.

115

115

STAT

JANUARY 16, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Bertagnolli’s burgeoning NIH agenda Monica Bertagnolli is just two months into directing the $48 billion NIH, but she has a  laundry list of challenges ahead of her.

113

113

Fierce Healthcare

JANUARY 16, 2024

Wages have not been able to offset the rising costs of premiums for workers with employer-sponsored coverage over the last three decades, with Black and Hispanic employers hit particularly hard by | The mean cumulative lost earnings from 1988 to 2019 due to increased premiums in employer-sponsored health plans come to $125,340 per family, according to a JAMA Network Open study.

112

112

PharmaVoice

JANUARY 16, 2024

On the heels of two FDA approvals for microbiome-based therapies, interest in the space is gaining steam.

FDA 111

FDA 111

Fierce Pharma

JANUARY 16, 2024

After crowning Keytruda as the first immunotherapy for advanced cervical cancer back in 2021, the FDA has awarded the drug another industry-first designation in an earlier stage of the tumor type. | After crowning Keytruda as the first immunotherapy for advanced cervical cancer back in 2021, the FDA has awarded the drug another industry-first designation in an earlier stage of the tumor type.

FDA 111

FDA 111

Drug Store News

JANUARY 16, 2024

Washington State Attorney General Bob Ferguson filed a lawsuit to block the proposed Kroger-Albertsons merger, saying that it will severely limit shopping options for consumers.

111

111